Legionnaires’ disease and gardening

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
R. Dumke, H. von Baum, P.C. Lück, E. Jacobs 
Genotypic diversity and antibiotic susceptibility of Acinetobacter baumannii isolates in a Bulgarian hospital  R. Dobrewski, E. Savov, A.T. Bernards,
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
Nosocomial infection caused by class 1 integron-carrying Staphylococcus aureus in a hospital in South China  Z. Xu, L. Shi, C. Zhang, L. Zhang, X. Li,
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
A.K. Reddy, P. Garg, I. Kaur  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
M. Montes, D. Vicente, O. Esnal, G. Cilla, E. Pérez-Trallero 
Assessment of fluorescent amplified fragment length polymorphism analysis for epidemiological genotyping of Legionella pneumophila serogroup 1  N.K. Fry,
R. Cantón  Clinical Microbiology and Infection 
Genital Chlamydia trachomatis infections
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Clinical Microbiology and Infection
Surveillance of Legionnaires’ disease in Austria
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Genotypic diversity and antibiotic susceptibility of Acinetobacter baumannii isolates in a Bulgarian hospital  R. Dobrewski, E. Savov, A.T. Bernards,
Nosocomial infection caused by class 1 integron-carrying Staphylococcus aureus in a hospital in South China  Z. Xu, L. Shi, C. Zhang, L. Zhang, X. Li,
Vector control: a cornerstone in the malaria elimination campaign
J.P. Donnelly, B.E. De Pauw  Clinical Microbiology and Infection 
Assessment of fluorescent amplified fragment length polymorphism analysis for epidemiological genotyping of Legionella pneumophila serogroup 1  N.K. Fry,
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
Amplified fragment length polymorphism analysis of human clinical isolates of Mycobacterium haemophilum from different continents  L.E.S. Bruijnesteijn.
B. Gordts  Clinical Microbiology and Infection 
Laboratory diagnosis and biosafety issues of biological warfare agents
CMI editorial report 2011 Clinical Microbiology and Infection
Comparison of clinical and environmental isolates of Legionella pneumophila obtained in the UK over 19 years  T.G. Harrison, N. Doshi, N.K. Fry, C.A.
Elements of design: the knowledge on which we build
Levofloxacin in the treatment of ventilator-associated pneumonia
Metagenomics and probiotics
Laboratory diagnosis of Clostridium difficile disease
The practice of travel medicine in Europe
T.M. File  Clinical Microbiology and Infection 
Update on antifungal resistance in Aspergillus and Candida
Antibacterial drug discovery in the 21st century
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial 
Increased incidence of methicillin-resistant Staphylococcus aureus ST80, novel ST125 and SCCmecIV in the south-eastern part of Norway during a 12-year.
Current experience in treating invasive zygomycosis with posaconazole
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida 
Antimicrobial drug development – the past, the present, and the future
Clinical infection services—the Leiden experience
An after-hours clinical liaison blood culture service—is it worth it?
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Listeriosis: a resurgent foodborne infection
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
A. van Samkar, M. C. Brouwer, Y. Pannekoek, A. van der Ende, D
The atypical pneumonias: clinical diagnosis and importance
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
B.A. Cunha  Clinical Microbiology and Infection 
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
High-throughput amplification fragment length polymorphism (htAFLP) analysis identifies genetic lineage markers but not complement phenotype-specific.
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Legionnaires’ disease and gardening J.W. den Boer, E.P.F. Yzerman, R. Jansen, J.P. Bruin, L.P.B. Verhoef, G. Neve, K. Van der Zwaluw  Clinical Microbiology and Infection  Volume 13, Issue 1, Pages 88-91 (January 2007) DOI: 10.1111/j.1469-0691.2006.01562.x Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Dendrogram of Legionella longbeachae isolates constructed using an amplified fragment length polymorphism assay. Clinical Microbiology and Infection 2007 13, 88-91DOI: (10.1111/j.1469-0691.2006.01562.x) Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions